Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: Noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4075-4078

  Aboagye, Eric O ^a   Artemov, Dmitri ^a   Senter, Peter D ^b   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; MONOCLONAL ANTIBODY; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MONITORING; DRUG SCREENING; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ANIMALS; FEMALE; FLUCYTOSINE; FLUORINE; FLUOROURACIL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PRODRUGS;

EID: 0032530939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wallace, P. M., MacMaster, J. F., Smith, V. F., Kerr, D. E., Senter, P. D., and Cosand, W. L. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res., 54: 2719-2723, 1994.
2. Senter, P. D., Su, P. C. D., Katsuragi, T., Sakai, T., Cosand, W. L., Hellstrom, I., and Hellstrom, K. E. Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates. Bioconjugate Chem., 2: 477-451, 1991.
3. Hellstrom, I., Horn, D., Linsley, P. S., Brown, J. P., Brankovan, V., and Hellstrom, K. E. Monoclonal antibodies raised against human lung carcinoma. Cancer Res., 46: 3917-3923, 1986.
4. Marken, J. S., Schieven, G. L., Hellstrom, I., Hellstrom, K. E., Aruffo, A. Cloning and expression of the tumor-associated antigen L6. Proc. Natl. Acad. Sci. USA, 89: 3503-3507, 1992.
5. Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., and Huber, B. E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res., 55: 4808-4812, 1995.
6. Harris, J. D., Gutierrez, A. A., Hurst, H. C., Sikora, K., and Lemoine, N. R. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther., 1: 170-175, 1994.
7. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 3519-3523, 1992.
8. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
9. Hanna, N. N., Mauceri, H. J., Wayne, J. D., Hallahan, D. E., Kufe, D. W., and Weichselbaum, R. R. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res., 57: 4205-4209, 1997.
10. Findlay, M. P., and Leach, M. O. In vivo monitoring of fluoropyrimidine metabolites: magnetic resonance spectroscopy in the evaluation of 5-fluorouracil. Anticancer Drugs, 5: 260-280, 1994.
11. 19F nuclear magnetic resonance spectroscopy. Cancer Res., 54: 4321-4326, 1994.
12. 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma. Magn. Reson. Imaging, 12: 497-511, 1994.
13. Presant, C. A., Wolf, W., Waluch, V., Wiseman, C., Kennedy, P., Blayney, D., and Brechner, R. R. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet, 343: 1184-1187, 1994.
14. 19F MR imaging of 5-fluorouracil and α-fluoro-β-alanine. Magn. Reson. Imaging, 11: 1193-1201, 1993.
15. Clark, E. A., Shu, G., and Ledbetter, J. A. Role of the Bp35 cell surface polypeptide in human B cell activation. Proc. Natl. Acad. Sci. USA, 82: 1766-1770, 1985.
16. Hellstrom, K. E., Yelton, D. E., Fell, H. P., Beaton, D., Gayle, M., MacLean, M., Kahn, M., and Hellstrom, I. Epilope mapping and use of anti-idiotypic antibodies to the L6 monoclonal antibodies raised against human lung carcinoma. Cancer Res., 50: 2449-2454, 1990.
17. Brown, T. R., Kincaid, B. M., and Ugurbil, K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA, 79: 3523-3526, 1982.